| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.82B | 12.91B | 13.31B | 12.41B | 16.04B | 15.52B |
| Gross Profit | 10.10B | 10.34B | 10.68B | 9.65B | 10.38B | 10.84B |
| EBITDA | 9.70B | 9.94B | 10.24B | 9.12B | 9.21B | 10.74B |
| Net Income | -463.00M | 891.00M | 4.77B | -8.86B | 4.39B | -7.85B |
Balance Sheet | ||||||
| Total Assets | 234.22B | 238.07B | 245.32B | 255.25B | 272.27B | 277.91B |
| Cash, Cash Equivalents and Short-Term Investments | 1.37B | 1.31B | 1.12B | 1.34B | 1.80B | 2.26B |
| Total Debt | 34.73B | 35.54B | 37.42B | 46.49B | 49.33B | 54.28B |
| Total Liabilities | 44.73B | 46.09B | 49.72B | 60.37B | 61.39B | 68.50B |
| Stockholders Equity | 185.23B | 187.82B | 191.41B | 190.36B | 206.11B | 204.55B |
Cash Flow | ||||||
| Free Cash Flow | 6.51B | 6.30B | 5.82B | 6.65B | 7.77B | 4.65B |
| Operating Cash Flow | 6.46B | 6.34B | 5.87B | 6.69B | 7.97B | 4.82B |
| Investing Cash Flow | -109.00M | -174.00M | 7.17B | -2.16B | 199.00M | -8.13B |
| Financing Cash Flow | -5.97B | -5.96B | -13.25B | -4.90B | -8.66B | 2.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$106.91B | 9.73 | 23.11% | 2.92% | 10.31% | 8.93% | |
72 Outperform | HK$67.65B | -17.53 | -2.32% | 5.04% | -3.87% | -124.27% | |
66 Neutral | HK$19.51B | 30.82 | 3.73% | 4.94% | 7.23% | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
62 Neutral | HK$44.80B | 23.45 | 1.35% | 5.92% | -9.76% | -28.29% | |
58 Neutral | HK$19.41B | 28.27 | 4.63% | 1.77% | 5.75% | -31.63% |